WILLIAM J. PETERS - 31 Jul 2024 Form 4 Insider Report for Amphastar Pharmaceuticals, Inc. (AMPH)

Signature
/s/ William J. Peters
Issuer symbol
AMPH
Transactions as of
31 Jul 2024
Net transactions value
-$246,768
Form type
4
Filing time
02 Aug 2024, 16:32:54 UTC
Previous filing
28 Jun 2024
Next filing
08 Nov 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AMPH Common Stock Options Exercise $208,005 +10,282 +11% $20.23 104,385 31 Jul 2024 Direct
transaction AMPH Common Stock Sale $454,773 -10,282 -9.9% $44.23 94,103 31 Jul 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AMPH Employee Stock Option (right to buy) Options Exercise $0 -10,282 -68% $0.000000 4,943 31 Jul 2024 Common Stock 10,282 $20.23 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2024.
F2 Shares subject to the option are fully vested and immediately exercisable.